Li Huang

3.3k total citations
100 papers, 2.8k citations indexed

About

Li Huang is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Li Huang has authored 100 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 34 papers in Infectious Diseases and 28 papers in Virology. Recurrent topics in Li Huang's work include HIV/AIDS drug development and treatment (33 papers), HIV Research and Treatment (28 papers) and Natural product bioactivities and synthesis (14 papers). Li Huang is often cited by papers focused on HIV/AIDS drug development and treatment (33 papers), HIV Research and Treatment (28 papers) and Natural product bioactivities and synthesis (14 papers). Li Huang collaborates with scholars based in United States, China and Taiwan. Li Huang's co-authors include Chin‐Ho Chen, Kuo‐Hsiung Lee, Phong Ho, Hideo Nakamura, Sheng Chu Kuo, Keduo Qian, Chin Chen, Chin Ho Chen, Yoshiki Kashiwada and Lei Zhu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Li Huang

97 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Huang United States 34 1.3k 808 569 522 294 100 2.8k
Xiao Ding China 28 1.2k 0.9× 745 0.9× 408 0.7× 282 0.5× 245 0.8× 118 2.7k
Keduo Qian United States 32 1.6k 1.2× 895 1.1× 349 0.6× 293 0.6× 298 1.0× 74 2.7k
Liu‐Meng Yang China 31 1.5k 1.2× 743 0.9× 446 0.8× 326 0.6× 281 1.0× 120 2.6k
Giosuè Costa Italy 30 1.4k 1.1× 388 0.5× 433 0.8× 216 0.4× 307 1.0× 107 2.5k
Elizabeth A. Gullen United States 24 713 0.5× 450 0.6× 406 0.7× 174 0.3× 151 0.5× 51 1.6k
Lan Xie China 26 629 0.5× 1.2k 1.5× 448 0.8× 363 0.7× 262 0.9× 83 2.1k
Robert Vince United States 35 2.2k 1.6× 1.4k 1.7× 1.3k 2.2× 665 1.3× 182 0.6× 155 4.0k
Alessandra Pani Italy 26 785 0.6× 606 0.8× 320 0.6× 185 0.4× 78 0.3× 86 2.1k
Ying Guo China 27 723 0.6× 363 0.4× 427 0.8× 174 0.3× 154 0.5× 79 1.6k
James R. Fuchs United States 45 2.7k 2.1× 1.3k 1.6× 1.0k 1.8× 980 1.9× 416 1.4× 112 5.6k

Countries citing papers authored by Li Huang

Since Specialization
Citations

This map shows the geographic impact of Li Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Huang more than expected).

Fields of papers citing papers by Li Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Huang. The network helps show where Li Huang may publish in the future.

Co-authorship network of co-authors of Li Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Li Huang. A scholar is included among the top collaborators of Li Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Huang. Li Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lan, Jing, Wei Dai, Hao Huang, et al.. (2025). A Review of Bavachinin and Its Derivatives as Multi‐Therapeutic Agents. Chemistry & Biodiversity. 22(6). e202402762–e202402762.
2.
Chen, Si, et al.. (2025). Correlation between early corneal edema and endothelial cell loss after phacoemulsification cataract surgery. Frontiers in Medicine. 12. 1562717–1562717.
3.
Kikuchi, Takashi, et al.. (2024). Anti-HIV diterpenoids from Daphne pseudomezereum. Phytochemistry. 232. 114366–114366. 1 indexed citations
4.
Kobayashi, Tsubasa, Kazuki Nakamura, Takashi Kikuchi, et al.. (2023). LC-MS identification, isolation, and structural elucidation of anti-HIV macrocyclic daphnane orthoesters from Edgeworthia chrysantha. Fitoterapia. 172. 105731–105731. 5 indexed citations
5.
Jiang, Zhaoxin, et al.. (2023). Pattern of choroidal thickness in early-onset high myopia. Frontiers in Medicine. 10. 1156259–1156259. 4 indexed citations
6.
Zhang, Zhaotian, Songshan Li, Limei Sun, et al.. (2022). Skills assessment after a grape-based microsurgical course for ophthalmology residents: randomised controlled trial. British Journal of Ophthalmology. 107(9). 1395–1402. 3 indexed citations
7.
Zhang, Mi, Takashi Kikuchi, Isao Azumaya, et al.. (2022). Daphnepedunins A–F, Anti-HIV Macrocyclic Daphnane Orthoester Diterpenoids from Daphne pedunculata. Journal of Natural Products. 85(12). 2856–2864. 11 indexed citations
8.
Zhang, Mi, Takashi Kikuchi, Di Zhou, et al.. (2021). Identification of anti-HIV macrocyclic daphnane orthoesters from Wikstroemia ligustrina by LC–MS analysis and phytochemical investigation. Journal of Natural Medicines. 75(4). 1058–1066. 15 indexed citations
9.
Dang, Zhao, Lei Zhu, Lan Xie, et al.. (2020). Design and Synthesis of Quinolizidine Derivatives as Influenza Virus and HIV-1 Inhibitors. Current Medicinal Chemistry. 28(24). 4995–5003. 3 indexed citations
10.
McDaniel, Kelly, Nan Wu, Tianhao Zhou, et al.. (2019). Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal‐7 microRNA. Hepatology. 69(6). 2562–2578. 34 indexed citations
11.
Dang, Zhao, Phong Ho, Lei Zhu, et al.. (2013). New Betulinic Acid Derivatives for Bevirimat-Resistant Human Immunodeficiency Virus Type-1. Journal of Medicinal Chemistry. 56(5). 2029–2037. 69 indexed citations
12.
Huang, Li, et al.. (2011). The Role of Dynamin in HIV Type 1 Env-Mediated Cell–Cell Fusion. AIDS Research and Human Retroviruses. 27(9). 1013–1017. 8 indexed citations
13.
Huang, Li, Xiang Mao, N.G. Abdulaev, et al.. (2011). One-step purification of a functional, constitutively activated form of visual arrestin. Protein Expression and Purification. 82(1). 55–60. 7 indexed citations
14.
Huang, Li, et al.. (2007). Induction of a Nonproductive Conformational Change in gp120 by a Small Molecule HIV Type 1 Entry Inhibitor. AIDS Research and Human Retroviruses. 23(1). 28–32. 13 indexed citations
15.
Huang, Li, Phong Ho, Kuo‐Hsiung Lee, & Chin‐Ho Chen. (2005). Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives. Bioorganic & Medicinal Chemistry. 14(7). 2279–2289. 70 indexed citations
16.
Lu, Chun, Yi Zeng, Zan Huang, et al.. (2005). Human Herpesvirus 6 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus. American Journal Of Pathology. 166(1). 173–183. 41 indexed citations
17.
Zhou, Jing, Li Huang, David L. Hachey, Chin Ho Chen, & Christopher Aiken. (2005). Inhibition of HIV-1 Maturation via Drug Association with the Viral Gag Protein in Immature HIV-1 Particles. Journal of Biological Chemistry. 280(51). 42149–42155. 77 indexed citations
18.
Huang, Li, et al.. (2004). Bifunctional Anti-Human Immunodeficiency Virus Type 1 Small Molecules with Two Novel Mechanisms of Action. Antimicrobial Agents and Chemotherapy. 48(2). 663–665. 41 indexed citations
19.
Huang, Li, et al.. (2004). Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564. Virology. 324(2). 525–530. 19 indexed citations
20.
Kashiwada, Yoshiki, Li Huang, Lawrence M. Ballas, et al.. (1994). New hexahydroxybiphenyl derivatives as inhibitors of protein kinase C. Journal of Medicinal Chemistry. 37(1). 195–200. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026